Leukemias are a group of acute and chronic hematological neoplasias characterized by the dissemination of the cancer cells originating in the bone marrow via the bloodstream. In 2016 the estimated number of new leukemia cases was more than 110,000 in all of Europe and 47,000 in the USA. Leukemias, cause of 4% of all cancer deaths and account for 3.6% of all cancers. Historically, leukemias have been divided into four major categories further classified into subtypes based on specific features of cells: acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous leukemia (AML), and chronic myelogenous leukemia (CML). A revised classification of myeloid/lymphoid neoplasms and leukemias has recently been published to better characterize each disease. This updated classification incorporated new scientific and clinical information to refine diagnostic criteria for previously described neoplasms and introduced newly recognized disease entities. In this chapter the main entities of leukemia, with specific regard to imaging for diagnosis, treatment response assessment, and follow-up, will be treated according to what reported in the clinical guidelines.

Sollini, M., Galimberti, S., Boni, R., Erba, P. (2017). Diagnostic applications of nuclear medicine: Leukemias. In H.W. Strauss, G. Mariani, D. Volterrani, S.M. Larson (a cura di), Nuclear Oncology From Pathophysiology to Clinical Applications (pp. 435-465). Springer International Publishing [10.1007/978-3-319-26236-9_39].

Diagnostic applications of nuclear medicine: Leukemias

Boni R.;Erba P. A.
2017

Abstract

Leukemias are a group of acute and chronic hematological neoplasias characterized by the dissemination of the cancer cells originating in the bone marrow via the bloodstream. In 2016 the estimated number of new leukemia cases was more than 110,000 in all of Europe and 47,000 in the USA. Leukemias, cause of 4% of all cancer deaths and account for 3.6% of all cancers. Historically, leukemias have been divided into four major categories further classified into subtypes based on specific features of cells: acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous leukemia (AML), and chronic myelogenous leukemia (CML). A revised classification of myeloid/lymphoid neoplasms and leukemias has recently been published to better characterize each disease. This updated classification incorporated new scientific and clinical information to refine diagnostic criteria for previously described neoplasms and introduced newly recognized disease entities. In this chapter the main entities of leukemia, with specific regard to imaging for diagnosis, treatment response assessment, and follow-up, will be treated according to what reported in the clinical guidelines.
Capitolo o saggio
Bone cancer; Hematological malignancies; Imaging; Leukemia;
English
Nuclear Oncology From Pathophysiology to Clinical Applications
Strauss, HW; Mariani, G; Volterrani, D; Larson, SM
2017
9783319262345
Springer International Publishing
435
465
Sollini, M., Galimberti, S., Boni, R., Erba, P. (2017). Diagnostic applications of nuclear medicine: Leukemias. In H.W. Strauss, G. Mariani, D. Volterrani, S.M. Larson (a cura di), Nuclear Oncology From Pathophysiology to Clinical Applications (pp. 435-465). Springer International Publishing [10.1007/978-3-319-26236-9_39].
reserved
File in questo prodotto:
File Dimensione Formato  
Sollini-2018-Nuclear Oncology-VoR.pdf

Solo gestori archivio

Descrizione: Contributo in libro
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 636.48 kB
Formato Adobe PDF
636.48 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/425240
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
Social impact